Literature DB >> 9165414

Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury.

C Mitaka1, Y Hirata, T Nagura, Y Tsunoda, M Itoh, K Amaha.   

Abstract

PURPOSE: This study was performed to elucidate the pathophysiological role of brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) in acute lung injury.
MATERIALS AND METHODS: We sequentially measured plasma concentrations of immunoreactive BNP and ANP in 10 patients (mean age, 63 years (with acute lung injury and compared those with hemodynamic parameters and pulmonary functions.
RESULTS: Plasma concentrations of immunoreactive BNP and ANP were markedly elevated at entry into the study. Plasma BNP concentrations during the early course (3 days) showed significant (P < .01) positive correlations with systemic vascular resistance index (r = .708) and pulmonary vascular resistance index (r = .573), but a negative correlation with cardiac index (r = .608). Plasma ANP concentrations showed a significant (P < .05) positive correlation with pulmonary capillary wedge pressure (r = .398). Plasma BNP in 4 patients who died and 1 patient with acute renal failure remained elevated during the entire hospital length of stay (12 days).
CONCLUSION: These findings suggest that circulating BNP plays an important role in acute lung injury along with ANP as a compensatory mechanism for cardiac dysfunction accompanied by increased systemic vascular resistance index and pulmonary vascular resistance index. Circulating BNP may be a sensitive humoral marker for the degree of ventricular dysfunction associated with acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165414     DOI: 10.1016/s0883-9441(97)90003-4

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  8 in total

1.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

2.  Prognostic value of natriuretic peptides in severe trauma patients with multiple organ dysfunction syndrome.

Authors:  Nan Li; Zhi Song; Jing Wang; Yue Teng; Yan Cui; Hongxu Jin; Yan Gao
Journal:  Exp Ther Med       Date:  2015-06-11       Impact factor: 2.447

3.  Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury.

Authors:  Bhupinder Reel; Peter E Oishi; Jong-Hau Hsu; Ginny Gildengorin; Michael A Matthay; Jeffrey R Fineman; Heidi Flori
Journal:  Pediatr Pulmonol       Date:  2009-11

4.  Natriuretic peptides: Diagnostic and therapeutic use.

Authors:  Kaushik Pandit; Pradip Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2011-10

5.  Serum levels of N-terminal proB-type natriuretic peptide in mechanically ventilated critically ill patients--relation to tidal volume size and development of acute respiratory distress syndrome.

Authors:  Rogier M Determann; Annick A N M Royakkers; Jacqueline Schaefers; Anita M de Boer; Jan M Binnekade; Jan P van Straalen; Marcus J Schultz
Journal:  BMC Pulm Med       Date:  2013-07-09       Impact factor: 3.317

6.  The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock.

Authors:  Govind Pandompatam; Kianoush Kashani; Saraschandra Vallabhajosyula
Journal:  Rev Bras Ter Intensiva       Date:  2019-10-14

Review 7.  Science review: natriuretic peptides in critical illness.

Authors:  Rochus Witthaut
Journal:  Crit Care       Date:  2004-06-17       Impact factor: 9.097

8.  B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis.

Authors:  Sabato Sorrentino; Michele Cacia; Isabella Leo; Alberto Polimeni; Jolanda Sabatino; Carmen Anna Maria Spaccarotella; Annalisa Mongiardo; Salvatore De Rosa; Ciro Indolfi
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.